Global Oryzanol Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Oryzanol Market Overview

The Oryzanol Market was valued at USD 4.60 Billion in 2025 and is projected to reach USD 9.81 Billion by 2033, growing at a CAGR of 9.93% from 2026 to 2033. The market is experiencing consistent growth driven by rising demand for natural antioxidant ingredients, increasing adoption of rice bran–derived nutraceuticals, and growing consumer preference for plant-based functional food additives. Expanding applications of oryzanol in pharmaceuticals, dietary supplements, cosmetics, and sports nutrition products are further supporting market growth across developed and emerging economies.

The increasing global focus on preventive healthcare and clean-label nutrition, combined with rising prevalence of lifestyle-related disorders such as cardiovascular diseases and high cholesterol, is significantly boosting demand for oryzanol-based formulations. Growing investments in nutraceutical R&D and expanding utilization of rice bran oil by-products in value-added health ingredients are further accelerating commercialization. In addition, rising awareness of antioxidant benefits and continuous product innovation in functional foods and supplements are strengthening long-term market expansion.

Key Market Trends & Insights

• North America dominated the Oryzanol Market with the largest revenue share of 47.2% in 2025, supported by strong demand for nutraceuticals, pharmaceuticals, and functional food ingredients with antioxidant and cholesterol-lowering benefits
• The rice bran oil segment led the market with a 70% share in 2025, driven by its naturally high oryzanol concentration and well-established extraction processes across large-scale rice milling industries
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 7.7% from 2026 to 2033, fueled by abundant availability of rice bran oil, rising nutraceutical consumption, and increasing awareness of preventive healthcare
• Nutraceuticals & sport supplements are the fastest-growing application type, projected to register a CAGR of 13% from 2026 to 2033, supported by rising consumer preference for natural performance-enhancing and wellness ingredients
• The pharmaceuticals segment dominated the application category with a 41% revenue share in 2025, led by increasing utilization of oryzanol in cholesterol management therapies and cardiovascular health formulations
• The wheat bran segment is the fastest-growing source category, with a CAGR of 12.5% from 2026 to 2033, driven by advancements in extraction technologies that improve yield efficiency of oryzanol compounds from non-traditional sources

Market Size & Forecast

• Global Market Value (2025): USD 4.60 Billion
• Expected Market Value (2033): USD 9.81 Billion
• Forecast CAGR (2026–2033): 9.93%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia-Pacific

Report Scope and Oryzanol Market Segmentation

Oryzanol Market Trends

Trend: Growing Demand for Plant-Based Antioxidants in Functional Foods

The Oryzanol market is witnessing a strong trend driven by increasing demand for plant-based antioxidants in functional foods, beverages, and dietary supplements. Consumers are shifting toward natural bioactive ingredients that support heart health, cholesterol reduction, and metabolic wellness, boosting the inclusion of gamma oryzanol derived from rice bran oil. Food and nutraceutical manufacturers are incorporating oryzanol into functional formulations due to its strong antioxidant and lipid-regulating properties.

For instance, Oryza Oil & Fat Chemical Co., Ltd. in Japan utilizes rice bran–derived gamma oryzanol in health-oriented food ingredient applications, supporting the growing clean-label and preventive nutrition trend.

Oryzanol Market Dynamics

Key Market Driver: Rising Lifestyle Diseases Driving Nutraceutical Adoption

The increasing prevalence of lifestyle-related diseases such as cardiovascular disorders, obesity, and high cholesterol is significantly driving demand for oryzanol-based nutraceutical products. Consumers are increasingly adopting preventive healthcare solutions, leading to higher consumption of natural cholesterol-lowering and antioxidant supplements. Pharmaceutical and nutraceutical companies are expanding their product portfolios to include rice bran–derived bioactives.

For instance, Ricela Health Foods Limited in India markets gamma oryzanol capsules targeted at cholesterol management, reflecting strong demand in preventive health applications.

Key Restraint/Challenge: Limited Awareness and High Extraction Costs Restrict Growth

The growth of the Oryzanol market is restrained by limited consumer awareness in several developing regions and the relatively high cost of extraction and purification from rice bran oil. Complex refining processes and variability in raw material quality increase production costs, impacting price competitiveness compared to synthetic alternatives. In addition, lack of widespread awareness about oryzanol’s health benefits slows adoption outside established nutraceutical markets.

This challenge is particularly evident in cost-sensitive markets where manufacturers face difficulty scaling production while maintaining affordability and product consistency.

Key Market Opportunity: Increasing Pharmaceutical Applications for Cholesterol Control

A significant opportunity in the Oryzanol market lies in its expanding pharmaceutical applications, particularly in cholesterol management and cardiovascular health therapies. Growing clinical interest in natural lipid-lowering agents is encouraging integration of gamma oryzanol into prescription-support and preventive drug formulations. Pharmaceutical and nutraceutical companies are increasingly investing in research to validate its therapeutic potential.

For instance, TSUNO Co., Ltd. in Japan has been involved in developing rice bran–based bioactive ingredients, including gamma oryzanol, for health-focused applications, highlighting its growing relevance in evidence-based pharmaceutical innovation.

Oryzanol Market Scope

The oryzanol market is segmented on the basis of source and application.

• By Source

On the basis of source, the Oryzanol Market is segmented into rice bran oil, wheat bran, fruits, and vegetables. The Rice Bran Oil segment dominated the market with the largest share of 70% in 2025, driven by its naturally high oryzanol concentration and well-established extraction processes across large-scale rice milling industries. The segment benefits from strong availability of raw materials in Asia-Pacific, where rice production is extensive and cost-efficient processing supports commercial viability. Increasing use of rice bran oil in functional food formulations and dietary supplements further strengthens its dominance. Continuous expansion of rice bran refining infrastructure supports stable supply and market leadership.

The Wheat Bran segment is projected to register the fastest growth at a CAGR of 12.5% from 2026 to 2033, driven by advancements in extraction technologies that improve yield efficiency of oryzanol compounds from non-traditional sources. Growing utilization of wheat processing by-products in nutraceutical applications is expanding its commercial relevance. Rising demand for cost-effective and diversified raw material sources is encouraging manufacturers to explore wheat bran-based extraction. Improved industrial valorization of cereal by-products is further accelerating adoption across food and supplement industries. Expanding research into alternative botanical sources continues to reinforce segment growth potential.

• By Application

On the basis of application, the Oryzanol Market is segmented into pharmaceuticals, cosmetics, nutraceuticals & sport supplements, and animal feed. The Pharmaceuticals segment dominated the market with a share of 41% in 2025, driven by increasing utilization of oryzanol in cholesterol management therapies and cardiovascular health formulations. Strong clinical interest in its antioxidant and lipid-regulating properties supports its widespread inclusion in pharmaceutical-grade products. Growing prevalence of lifestyle-related disorders is reinforcing demand for preventive healthcare solutions. Established regulatory acceptance in therapeutic formulations further strengthens its leading position. Continuous research into bioactive compounds ensures sustained pharmaceutical adoption.

The Nutraceuticals & Sport Supplements segment is projected to register the fastest growth at a CAGR of 13% from 2026 to 2033, driven by rising consumer preference for natural performance-enhancing and wellness ingredients. Increasing awareness of fitness, metabolic health, and antioxidant supplementation is expanding product penetration across global dietary supplement markets. Expanding sports nutrition industry is further accelerating demand for oryzanol-based formulations. Growing shift toward plant-derived functional ingredients supports rapid commercialization in this segment. Continuous product innovation in capsules, powders, and fortified foods is reinforcing strong growth momentum.

Oryzanol Market Regional Analysis

North America dominated the oryzanol market and accounted for the largest revenue share of 47.2% in 2025, driven by strong demand for nutraceuticals, pharmaceuticals, and functional food ingredients with antioxidant and cholesterol-lowering benefits. The region benefits from high consumer awareness regarding preventive healthcare, widespread adoption of dietary supplements, and strong integration of plant-based bioactive compounds in health formulations. Advanced food processing infrastructure and established pharmaceutical manufacturing capabilities further support large-scale utilization of oryzanol. In addition, strong presence of supplement manufacturers and growing clean-label product demand continue to reinforce North America’s leadership in the global market.

U.S. Oryzanol Market Insight

The U.S. Oryzanol market is witnessing strong growth driven by rising demand for cholesterol management supplements, expanding sports nutrition industry, and increasing preference for plant-derived functional ingredients. Consumers are increasingly shifting toward natural antioxidants for cardiovascular and metabolic health support, boosting adoption across nutraceutical and pharmaceutical applications. Strong R&D investments in bioactive compounds and advanced formulation technologies are further enhancing product innovation. In addition, the presence of major dietary supplement brands and well-established retail distribution networks is accelerating market expansion across the U.S.

Canada Oryzanol Market Insight

The Canada Oryzanol market is experiencing steady growth supported by rising health-conscious consumer behavior and increasing adoption of natural dietary supplements. Demand is growing across nutraceutical and cosmetic applications due to strong preference for clean-label and plant-based ingredients. Expanding retail penetration of functional foods and wellness products is further strengthening market uptake. In addition, growing awareness of preventive healthcare and increasing use of antioxidant-rich formulations are contributing to sustained market growth in Canada.

Europe Oryzanol Market Insight

The Europe Oryzanol market is expanding steadily due to rising demand for natural health ingredients, strong nutraceutical consumption, and increasing focus on preventive healthcare solutions. The region benefits from strict regulatory frameworks that encourage safe and high-quality bioactive ingredient usage in pharmaceuticals and functional foods. Growing adoption of plant-based cosmetics and anti-aging formulations is further supporting market expansion. In addition, strong research activities in bioactive compounds and increasing consumer shift toward natural wellness products continue to drive regional growth.

U.K. Oryzanol Market Insight

The U.K. Oryzanol market is growing steadily driven by increasing demand for dietary supplements, rising awareness of cardiovascular health, and strong expansion of the functional food industry. Consumers are increasingly adopting natural antioxidant-based formulations for fitness and wellness applications. The presence of a well-developed nutraceutical retail ecosystem and strong e-commerce penetration is supporting product accessibility. In addition, growing focus on clean-label ingredients and preventive healthcare trends is further strengthening market demand in the U.K.

Germany Oryzanol Market Insight

The Germany Oryzanol market is expanding due to strong demand for high-quality nutraceuticals, increasing adoption of plant-based pharmaceutical ingredients, and rising focus on wellness-oriented consumer products. The country’s advanced pharmaceutical manufacturing base supports large-scale integration of bioactive compounds in health formulations. Growing preference for organic and natural ingredients in cosmetics and functional foods is further driving market growth. In addition, strong regulatory standards emphasizing product safety and efficacy continue to reinforce adoption in Germany.

Asia-Pacific Oryzanol Market Insight

The Asia-Pacific Oryzanol market is expected to register the fastest growth with a CAGR of 7.7% from 2026 to 2033, driven by abundant availability of rice bran oil, rising nutraceutical consumption, and increasing awareness of preventive healthcare. Expanding middle-class population and growing demand for functional foods and dietary supplements are significantly boosting market adoption. Countries such as China, India, Japan, and South Korea are witnessing strong growth in pharmaceutical and wellness applications of oryzanol. In addition, rapid expansion of food processing industries and increasing investments in plant-based ingredient manufacturing are accelerating regional market growth.

Japan Oryzanol Market Insight

The Japan Oryzanol market is witnessing steady growth supported by high consumer focus on health and longevity, strong demand for functional foods, and established use of rice bran-derived bioactives. The country’s advanced food technology sector enables efficient extraction and formulation of oryzanol-based products. Increasing adoption in anti-aging cosmetics and cardiovascular health supplements is further supporting market expansion. In addition, strong R&D activities in nutraceutical innovation continue to enhance product development in Japan.

China Oryzanol Market Insight

The China Oryzanol market is growing rapidly due to large-scale rice production, expanding nutraceutical industry, and rising consumer shift toward natural health supplements. Increasing demand for cholesterol-lowering and antioxidant-rich formulations is driving adoption across pharmaceutical and dietary supplement sectors. Strong domestic manufacturing capabilities and growing investment in functional food innovation are further supporting market expansion. In addition, rising health awareness and rapid growth of e-commerce distribution channels are accelerating market penetration in China.

Oryzanol Market Share

The oryzanol industry is primarily led by well-established companies, including:

• Suzanne’s Specialties (U.S.)
• Nature’s One, Inc. (U.S.)
• Wuhu Deli Foods Co. Ltd. (China)
• Axiom Foods (U.S.)
• California Natural Products (U.S.)
• Associated British Foods Plc (U.K.)
• Cargill, Incorporated (U.S.)
• ADM (U.S.)
• Wuhu Haoyikuai Food Co. Ltd. (China)
• Gulshan Polyols Ltd. (India)
• RiceBran Technologies (U.S.)
• Oryza Oil & Fat Chemical Co., Ltd. (Japan)
• Wilmar International Ltd. (Singapore)
• Bunge Global S.A. (U.S.)
• Louis Dreyfus Company B.V. (Netherlands)
• Richardson International Limited (Canada)
• KTC (Krung Thai Co., Ltd.) (Thailand)
• Siam Vegetable Oil Co., Ltd. (Thailand)

Latest Developments in Oryzanol Market

• In July 2025, KRBL Limited expanded its presence in the wellness and functional food segment through its “India Gate Uplife” initiative, integrating rice bran–based health positioning aligned with natural bioactives such as oryzanol. This development strengthens the company’s diversification strategy by moving beyond traditional rice products into health-oriented FMCG offerings, thereby increasing value-added utilization of rice by-products and supporting demand growth for oryzanol-linked functional ingredients
• In 2024, Ricela Health Foods Limited expanded its gamma oryzanol capsule portfolio across emerging South Asian markets, reinforcing its nutraceutical positioning in cholesterol management and cardiovascular wellness. This development enhances market penetration by increasing accessibility of standardized oryzanol supplements, strengthening consumer adoption in preventive healthcare, and supporting the company’s leadership in rice bran–based nutraceuticals
• In 2024, TSUNO Co., Ltd. advanced its functional food portfolio by launching rice-based bakery products enriched with rice bran bioactives, including gamma oryzanol, targeting clean-label and wellness-focused consumers in Japan. This development expands the application base of oryzanol into mainstream food products, increasing consumer exposure beyond supplements and strengthening demand in functional bakery and fortified food categories
• In 2023, TSUNO Co., Ltd. strengthened its rice bran ingredient business by expanding industrial-scale production and refining capabilities for rice bran oil derivatives, including gamma oryzanol extraction. This development improves supply chain efficiency and ensures stable availability of high-purity oryzanol, supporting downstream growth in nutraceuticals, cosmetics, and functional food manufacturing
• In 2023, Ricela Health Foods Limited enhanced its nutraceutical manufacturing capabilities by scaling production of rice bran oil–derived gamma oryzanol ingredients for dietary supplement applications. This development strengthens its competitive position in the global nutraceutical supply chain by improving production capacity, reducing costs, and supporting rising international demand for plant-based cholesterol management solutions

SKU-53685